These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1315534)

  • 21. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.
    Hung DT; Vu TH; Nelken NA; Coughlin SR
    J Cell Biol; 1992 Feb; 116(3):827-32. PubMed ID: 1309820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides.
    Huang RS; Sorisky A; Church WR; Simons ER; Rittenhouse SE
    J Biol Chem; 1991 Oct; 266(28):18435-8. PubMed ID: 1655750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a potent thrombin receptor ligand.
    Feng DM; Veber DF; Connolly TM; Condra C; Tang MJ; Nutt RF
    J Med Chem; 1995 Sep; 38(20):4125-30. PubMed ID: 7562949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
    Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
    Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains.
    Gralnick HR; Williams S; McKeown LP; Hansmann K; Fenton JW; Krutzsch H
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6334-8. PubMed ID: 8022782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
    Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.
    Pumiglia KM; Feinstein MB
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):253-60. PubMed ID: 7689831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
    Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
    Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.
    Ma L; Hollenberg MD; Wallace JL
    Br J Pharmacol; 2001 Oct; 134(4):701-4. PubMed ID: 11606309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cleaved peptide of the thrombin receptor is a strong platelet agonist.
    Furman MI; Liu L; Benoit SE; Becker RC; Barnard MR; Michelson AD
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3082-7. PubMed ID: 9501219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.
    Suidan HS; Clemetson KJ; Brown-Luedi M; Niclou SP; Clemetson JM; Tschopp J; Monard D
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):939-45. PubMed ID: 8645180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.
    Hung DT; Vu TK; Wheaton VI; Charo IF; Nelken NA; Esmon N; Esmon CT; Coughlin SR
    J Clin Invest; 1992 Feb; 89(2):444-50. PubMed ID: 1310695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide.
    Blackhart BD; Ruslim-Litrus L; Lu CC; Alves VL; Teng W; Scarborough RM; Reynolds EE; Oksenberg D
    Mol Pharmacol; 2000 Dec; 58(6):1178-87. PubMed ID: 11093752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathepsin G and thrombin: evidence for two different platelet receptors.
    Selak MA
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):269-75. PubMed ID: 8297330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides.
    Hollenberg MD; Saifeddine M
    Can J Physiol Pharmacol; 2001 May; 79(5):439-42. PubMed ID: 11405248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.